NCT00139152.
Trial name or title | Non‐invasive ways to evaluate lung disease after treatment with Xolair |
Methods | Randomised, double‐blind, parallel‐group study |
Participants | People with stable asthma. 12 years of age and older |
Interventions | Xolair 0.016 mg/kg IgE, SQ versus saline placebo |
Outcomes | Levels of pH, nitrate/nitrite in exhaled breath condensate before and after four months of treatment |
Starting date | September 2005 |
Contact information | http://clinicaltrials.gov/ct2/show/NCT00139152 |
Notes |